Stock analysis for Alaunos Therapeutics Inc (ZIOP:US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Jan 26, 2022 · HOUSTON, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (“Ziopharm” or the “Company”) (Nasdaq: ZIOP), today announced that it will report... • Over …

3 days ago · Should You Buy or Sell ZIOPHARM Oncology Stock? Get The Latest ZIOP Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.

ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which is seeking to develop, acquire and commercialize, on its own or with partners, a portfolio of cancer therapies that address …

Aug 5, 2025 · ZIOP stood for ZIOPHARM Oncology, a clinical-stage biopharmaceutical company focused on developing personalized, gene-modified T-cell therapies to treat solid tumors.

View ZIOPHARM Oncology (ZIOP) stock price, news, historical charts, analyst ratings, and quotes on Tiger Brokers' website. Trade with advanced market insights on Tiger Trade app.

Welcome to the overview page for ZIOP (ZIOP), where you can find comprehensive stock information and company updates. Explore the latest news on strategic partnerships, quarterly …

May 3, 2019 · Get the latest %COMPANY_NAME% ZIOP detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Jan 26, 2022 · Ziopharm Ocology Inc (NASDAQ: ZIOP) has rebranded itself and has changed its name to Alaunos Therapeutics Inc. The Company will trade on NASDAQ under the new ticker …

Nov 21, 2025 · The market cap of ZIOPHARM Oncology (ZIOP) is $7.06M as of Nov 21, 2025. Track current and historical market cap trends with AI-powered fundamental data and custom …